Insight happens when data meets expertise

We are pricing & market access experts combining business intelligence data and human expertise. We help market access professionals find better insights, faster, through our consulting and digital next-generation market access tools.

More about us arrow_forward

Access Infinity named top 5 UK Pharma Tech Company

Pharma Tech Outlook has awarded us as a top 5 pharma tech company in UK for 2021

Read more arrow_forward

You’re in good company

We come in two flavours


The critical support you need to develop a successful value assessment and launch strategy


Our cloud-based apps for rapid business intelligence, KPI tracking, access and evidence planning

Group 2

Our consulting services

Group 3
Pricing and launch strategy

Optimise your pricing strategy and learn from in-depth qualitative and quantitative price assessments.

Group 4
Evidence gap

Find gaps in your evidence by testing with our extensive payer network spanning 40+ countries.

Group 1
Multi-indication price

Target your optimal price and assess the value of products in multiple indications.

Fast due

Get rapid due diligence assessments – conducted with the attention and expertise they deserve.


Unlock rigorous secondary research and analogue analysis using our own BI solution, Nuro.

Revenue optimisation
Excel tools

Go deeper with our revenue optimisation, budget impact, IRP and scenario comparison tools.

Group 5

Our products

All of your market access insights in a single platform

Nuro is a comprehensive data platform that brings together HTA Insights, Evidence, Pricing Intelligence, & other critical business insights all under one roof.

Showcasing your brand success through market access KPIs

Your single source of truth for tracking launch activities and market access KPIs across products and indications

The right evidence when you need it

Built from the ground up for HEOR/Medical teams to help track evidence generation projects and rapidly identify studies & publications of interest

What our clients are saying

Access Infinity provided excellent in-depth insights and guidance in key global markets, I've been very pleased with their responsiveness and the quality of work.

Kevin La Wall Commercial Director, Infectious Diseases, GSK

    Our global reach

    0 %
    0 %
    Win rate
    1000 +
    Number of
    30 +
    Countries in which we’ve conducted payer research in the last 5 years

    Get in touch

    Have a question about our consulting services or digital tools? Drop us a note and we will be in touch.